Categories: Health

Pharmacy Board Approves Cancer Drug for Early Stage Therapy

The Pharmacy and Poisons Board has approved the use of a prescription drug for the treatment of prostate cancer.

The drug, ZYTIGA (abiraterone acetate), is manufactured by Janssen, one of the pharmaceutical companies of Johnson & Johnson.

The local pharmacy regulator has approved the use of the once-daily medication for the treatment of metastatic castration-resistant prostate cancer ahead of a chemotherapy regime.

“The drug is only licensed for the treatment of advanced prostate cancer cases post-chemotherapy,” Janssen Kenya Country Manager Marseille Onyango said.

Albert Echetah

Recent Posts

Pastef party led by Ousmane Sonko wins historic election victory

Senegal's ruling Pastef party has won a resounding victory in the legislative elections, taking130 of the 165 seats in parliament,…

November 22, 2024

Famine Risk Reaches Critical Levels as FoodCrisis Deepens In Gaza

Gaza’s hunger crisis is not only statistic, but a set of narratives such as Yasmin Eid, amother of six, who…

November 22, 2024

Kenya Launches Official Probe intoUgandan Leader’s Alleged Kidnapping

The government of Kenya announced that it is looking into the suspected kidnapping ofKizza Besigye, a well-known opposition politician from…

November 22, 2024

At least 7 members of the Nigerian security forces are missing after insurgentsambushed their convoy

A team of 80 security agents tasked with protecting the electricity grid was ambushed onMonday in Shiroro, Niger State, by…

November 21, 2024

Cryptocurrency Gains Momentum inAfrica Amid Global Shifts in Trump’sElection

Cryptocurrency becomes the new thing in Africa. People shift for stable alternatives aftertheir unstable local currencies. Many people believe Donald…

November 21, 2024

UAE Delivers Lifeline: 30,000 Food BasketsBring Hope to Sudanese Refugees in Uganda

UAE has also distributed 30,000 food baskets to Sudanese refugees in Kiryandongo refugeecamp Uganda to benefit nearly 100,000 affected people.Aid…

November 21, 2024

This website uses cookies.